BIO Professional Development
Through a curated network of education alliance partners, BIO offers industry professionals executive training and development resources for accelerating career growth
05/16/2023 - 05/18/2023 | 12:00 PM - 4:00 PM EDT
Introduction to Drug Valuation
Introduction to Drug Valuation (formally called Biopharma Revenue Forecasting That Drives Decision Marking and Investment) is a tactical course invaluable for organizations that work in both preclinical/early clinical development all the way to mature biopharma. Develop knowledge of the core elements of drug valuation, including pricing, competitive assessments, and epidemiology. Understand how the geography of the US, EU, Japan, China, and the rest of the world impacts drug valuation. Join our industry experts as they bring to life the ‘logical process’ of drug valuation using real-life case studies that participants work through together.
The scope of this course includes:
- Geography: US, EU5, Japan, China, ROW
- Therapeutic area: oncology, specialty, rare diseases, gene therapy
Course Instructor(s):
Russ Belden and Bill Cacheris
Who should attend
Appropriate for those who need a foundational understanding of drug valuation and how it pertains to drug pricing. Ideal for anyone who works in finance, marketing, business development, project management, and research development.
Takeaways
- Develop a broad understanding of how and why revenue forecasts are developed to drive strategic decision-making and investing in the biopharma industry.
- Become fluent in the core elements of revenue forecasting including epidemiology, competitive assessments, market share assignment, duration of therapy, pricing, gross-to-net margins, and annual price increases.
- Understand how revenue forecasting varies across geographies and the considerations that need to be accounted for.
- Demonstrate the logical process (workstreams) that leads to effective, defensible revenue forecasting and the interpretation of its findings.
- Generate insights and actionable decisions from the forecasting process.
Certificate Requirements
- Attend the entire live course via Zoom
- Upon completion of the course, download your course certificate from your “User Dashboard”
Experienced dealmakers will prove a deep dive on early capitalization from investors (not grants).
Learn about the science driving today’s hottest biopharma innovations including CRISPR, CAR-T, gene therapy, and much more...
Gain a systematic approach to producing a valuation that can be used in investment rounds, mergers/acquisitions, licensing deals or strategic development decisions in the pharma-biotech world...
.png){kind=logo}
